| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |